Ogilvie syndrome primary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Overview
- Effective measures for the primary prevention of Ogilvie syndrome include supportive care measures as treatment of the underlying cause of the obstruction, terminating the concurrent medications that may cause intestinal dysmotility, and administration of intravenous fluids and saline.
Ogilvie syndrome
Ogilvie syndrome
- Supportive care is recommended in patients with colonic pseduo-obstruction in order to prevent the development of serious complications like intestinal perforation. It can be performed in the first few days after diagnosing the colonic pseudo-obstruction as long as there is no severe pain or extreme abdominal distension.[1]
- The supportive measures include the following:[2]
- Following up of any underlying cause like heart failure or infection
- Terminating any concurrent medication that may cause intestinal dysmotility like opoids and calcium channel blockers
- Administration of intravenous saline and fluids in order to preserve the normal body homeostasis
- Placement of the patients in a prone position with elevation of the hips
References
References
- ↑ Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF; et al. (2002). “Acute colonic pseudo-obstruction”. Gastrointest Endosc. 56 (6): 789–92. PMID 12447286.
- ↑ Sloyer AF, Panella VS, Demas BE, Shike M, Lightdale CJ, Winawer SJ; et al. (1988). “Ogilvie’s syndrome. Successful management without colonoscopy”. Dig Dis Sci. 33 (11): 1391–6. PMID 3180976.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH